Notice of Annual Report and A

RNS Number : 7758A

Synairgen plc

14 October 2009

 



Synairgen plc

('Synairgen' or the 'Company')

Notice of Annual Report and Accounts and Annual General Meeting

Southampton, UK - 14 October 2009: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company with a particular focus on viral defence in asthma and chronic obstructive pulmonary disease ('COPD'), announces that the Company's Annual Report and Accounts for the year ended 30 June 2009 has been posted to shareholders. A copy of the report can be found on the Company's website: www.synairgen.com.

Synairgen's 2009 Annual General Meeting ('AGM') will be held at 12 noon on Wednesday 11 November 2009 at the offices of Fasken Martineau LLP, 17 Hanover Square, London W1S 1HU. The Notice of the AGM is included in the Annual Report and Accounts.

-Ends-

For further information, please contact: 

Synairgen plc                                          Tel: + 44 (0) 23 8051 2800 

Richard Marsden, Chief Executive Officer 

John Ward, Finance Director 

Matrix Corporate Capital                          Tel: + 44 (0) 20 3206 7000 

Alastair Stratton 

Anu Tayal 

Threadneedle Communications               Tel: + 44 (0) 20 7653 9850 

Graham Herring 

Josh Royston

 

END

 

 

MSCFGMMGFDDGLZM